ReviewAntibodies (Basel, Switzerland)2022

Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines.

Mohammad Reza Sepand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.